4//SEC Filing
Strauss David Eric 4
Accession 0001799869-20-000002
CIK 0001358403other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:10 PM ET
Size
5.5 KB
Accession
0001799869-20-000002
Insider Transaction Report
Form 4
Strauss David Eric
Director, Corporate Controller
Transactions
- Award
Stock Option (right to buy)
2020-01-31+156,000→ 156,000 totalExercise: $1.22Exp: 2030-01-30→ Common Stock (156,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest and become exercisable on January 31, 2021, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.
Documents
Issuer
BELLICUM PHARMACEUTICALS, INC
CIK 0001358403
Entity typeother
Related Parties
1- filerCIK 0001799869
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 5:10 PM ET
- Size
- 5.5 KB